Appointments

The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.

Ivan Tornos will shift from COO to CEO of Zimmer Biomet now that former CEO Bryan Hanson has accepted the CEO job at 3M’s health care spinoff.

An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.

Against a globally tough environment, recruitment for EU medtech regulatory roles slowed down. Elemed’s Elena Kyria explains what is shaping talent hiring now there are signs of an uptick and how job seekers and recruiters can best position themselves

The company is shrinking its work force and real estate footprint in a bid to save money.

Francis deSouza resigned as CEO and chairman of Illumina just a few weeks after winning the support of shareholders. General counsel Charles Dadswell will take over as interim CEO.

An interactive summary of recent executive-level company changes and promotions in the medical device and diagnostics sectors.

Ken Washington, the former general manager of consumer robotics, will help the company “accelerate innovation-driven growth.”

Carl Icahn was successful in ousting Illumina’s chair, however its CEO, Francis deSouza remains. Both analysts and investors believe this could further encourage Illumina to divest Grail.

The handheld ultrasound company made a loss last quarter, but secured FDA authorization for a new ultrasound software and named new leadership.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries. Highlights include the appointment of a new head at the troubled Butterfly Network and Kevin Thornal's jump from Hologic to Nevro, where he is now CEO.

Thornal will replace Keith Grossman who is retiring. Investors and analysts hope Thornal will help the spinal cord stimulation company reach profitability by growing its “core” chronic pain business.

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.  

An interactive view of medtech and diagnostics executive changes from the month of February 2023.

In this new series titled Getting Personal, we talk to new and veteran senior executives about their journeys to corporate leadership, their motivations, passions, and the peaks and valleys of running a medtech company. Medtech Insight talked with Ken Stein, Boston Scientific’s global chief medical officer about his own diagnosis with atrial fibrillation and advice for others living with the disease, innovative technologies in development at Boston Scientific, and some of his proudest and more challenging times on the job, as well as his advice for other physicians who are contemplating a move into the corporate world.

Former Oracle cloud expert Troy Tazbaz brings cloud computing expertise to his new role as director of the Food and Drug Administration’s Digital Health Center of Excellence (DHCOE).